Truthout
Drug Pricing
Big Pharma and GOP Open About Plans to Obstruct Medicare Drug Price Reforms
While the reforms are less ambitious than what progressives wanted, they could still have a significant impact on costs.
$35 Insulin Caps for Medicare Patients Is Not Enough
In 2021, nearly 1 in 5 U.S. adults with diabetes rationed their insulin. Most are not covered by the new price cap.
Pharma Claims Drug Price Reform Hurts Innovation. Experts Say That’s “Bullshit.”
As the Senate moved to adopt modest drug pricing negotiation measures, pharmaceutical companies made specious arguments.
Schumer Pledges to Bring $35 Insulin Cap to Another Vote to Bring “Heat” to GOP
Republicans are facing a deluge of criticism for blocking the potentially life-saving proposal.
GOP Votes Down Plan to Cap Insulin Prices at $35 in Win for Big Pharma
Only seven Republicans joined Democrats to pass the proposal, which needed 60 votes to advance.
Pharma Complains of “Tragic Loss” as Dems Take Modest Action to Curb Drug Prices
The Inflation Reduction Act requires Medicare to negotiate the prices of a small number of prescription drugs.
Schumer: Inflation Reduction Act Has Votes to Pass After Concessions to Sinema
Democrats removed a proposal to block hedge fund managers from dodging millions in taxes on Sinema’s behalf.
GOP Opposition to Drug Pricing Bill Shows Scope of Big Pharma’s Grip on Congress
Republicans are opposing legislation that would lower drug costs for millions.
Sanders: Democrats’ Drug Pricing Plan “Goes Nowhere Near as Far as It Should”
Sen. Bernie Sanders suggested that pharmaceutical industry lobbying weakened the proposal.
Pharma Is Mobilizing to Tank Democrats’ Effort to Cut Prescription Drug Costs
The pharmaceutical industry is mobilizing its army of lobbyists to attack Senate Democrats' Medicare drug pricing plan.